Biotech Breakthroughs

Results

55

1 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

55 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	MDGL	US$519.09	2.3%	25.2%	US$12.0b	US$678.06	9.3	63.7%	n/a	Pharmaceuticals & Biotech
	INSM	US$125.08	1.1%	-5.2%	US$27.3b	US$200.05	24.0	67.0%	n/a	Pharmaceuticals & Biotech
	PRAX	US$364.58	-1.1%	686.1%	US$10.8b	US$638.68	7.6	71.7%	n/a	Pharmaceuticals & Biotech
	ANAB	US$56.69	1.2%	178.4%	US$1.8b	US$87.09	7.2	48.1%	39.7%	Pharmaceuticals & Biotech
	MRKR	US$1.22	7.0%	-5.4%	US$20.2m	US$7.87	7.6	72.5%	n/a	Pharmaceuticals & Biotech
	ARDX	US$3.90	-3.9%	-36.2%	US$971.8m	US$12.90	2.2	61.5%	n/a	Pharmaceuticals & Biotech
	ZYME	US$26.57	3.1%	84.6%	US$1.9b	US$40.33	50.8	39.6%	n/a	Pharmaceuticals & Biotech
	IONS	US$58.76	2.7%	37.6%	US$9.8b	US$88.00	11.2	68.7%	n/a	Pharmaceuticals & Biotech
	TNYA	US$0.69	-5.8%	-40.5%	US$159.9m	US$3.20	116.0	67.8%	n/a	Pharmaceuticals & Biotech
	RNXT	US$1.32	4.8%	47.8%	US$59.3m	US$7.00	30.1	77.2%	n/a	Pharmaceuticals & Biotech
	CAPR	US$6.84	62.4%	-2.6%	US$463.9m	US$10.50	1.6	62.7%	n/a	Pharmaceuticals & Biotech
	LCTX	US$1.08	1.9%	-7.7%	US$278.2m	US$5.50	20.9	74.5%	n/a	Pharmaceuticals & Biotech
	CLRB	US$2.59	-0.4%	-46.9%	US$24.5m	US$11.50	0.8	56.0%	n/a	Pharmaceuticals & Biotech
	INMB	US$2.16	-0.5%	-10.4%	US$60.2m	US$7.00	2.9	43.4%	n/a	Pharmaceuticals & Biotech
	ABEO	US$5.96	-0.4%	-17.6%	US$340.8m	US$18.86	13.4	70.2%	n/a	Pharmaceuticals & Biotech
	RVMD	US$211.74	4.8%	480.4%	US$46.0b	US$221.90	17.4	60.0%	n/a	Pharmaceuticals & Biotech
	ALDX	US$1.50	-3.8%	-74.2%	US$90.5m	US$6.60	2.4	55.2%	n/a	Pharmaceuticals & Biotech
	VRDN	US$24.50	11.4%	36.0%	US$2.8b	US$36.63	39.0	63.0%	n/a	Pharmaceuticals & Biotech
	ACIU	US$2.64	2.7%	25.7%	US$256.5m	US$8.67	12.0	45.3%	n/a	Pharmaceuticals & Biotech
	CGON	US$77.61	3.9%	198.7%	US$7.2b	US$91.08	1104.6	62.0%	n/a	Pharmaceuticals & Biotech
	LGVN	US$0.83	11.9%	3.6%	US$26.3m	US$7.15	22.2	60.1%	n/a	Pharmaceuticals & Biotech
	VERA	US$31.26	8.2%	38.3%	US$2.3b	US$77.14	5.5	65.8%	n/a	Pharmaceuticals & Biotech
	NAMS	US$27.78	4.2%	13.7%	US$3.4b	US$51.44	466.3	65.3%	n/a	Pharmaceuticals & Biotech
	LRMR	US$4.16	-4.6%	6.4%	US$433.7m	US$14.30	3.4	51.7%	n/a	Pharmaceuticals & Biotech

Page 1 of 2